No reimbursed personal expenses reported for April, 2023
$0.00
Employer | Amount |
---|---|
Prime Therapeutics, LLC | 2261.18 |
No payments to sub-contracted lobbyists reported for April, 2023
No itemized entertainment expenses reported for April, 2023
No non-itemized entertainment expenses reported for April, 2023
No itemized contributions by employer reported for April, 2023
No itemized contributions by employer's PAC reported for April, 2023
No other itemized contributions reported for April, 2023
No non-itemized contributions by employer reported for April, 2023
0.00
No PAC contribution activity reported for April, 2023
No advertising expenses reported for April, 2023
No political advertising expenses reported for April, 2023
No other lobbying expenses reported for April, 2023
Employer | Subject Matter of Proposed Legislation | Issue or bill number | Persons, Legislative committee or State Agency considering the matter |
---|---|---|---|
Prime Therapeutics, LLC | Health Care | SB 5066 | House Committee on Health Care and Wellness; Appropriations Committee |
Prime Therapeutics, LLC | Health Care | HB 1357 | Senate Health and Long Term Care Committee; Ways and Means Committee |
Prime Therapeutics, LLC | Health Care | SB 5729 | Senate Rules Committee |
Prime Therapeutics, LLC | Health Care | SB 5300 | Senate Health and Long Term Care Committee |
100.00%
Percent of time spent lobbying state agencies.0.00%